- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04191564
Effect of Anesthetic Conditions on Stapling Thickness and Quality
December 6, 2019 updated by: Jan Mulier, AZ Sint-Jan AV
Impact of Low Perfusion by High Intraabdominal Pressure and Low Blood Pressure on Stapling Quality Measured as Thickness Difference Between Staples and Stomach Wall and by Bursting Pressure of Excluded Stomach
the excluded stomach during sleeve gastrectomy can be investigated post removal outside the patient.
During stapling it is common to reduce systolic arterial blood pressure (SAP) below 100 mmHg to reduce peritoneal perfusion and have better compression.
Higher intra abdominal pressures reduce also the peritoneal and mucosal perfusion and might help to improve stapling compression.
Stapling compression can be evaluated by measuring stapling thickness and compare it with stomach wall thickness or by measuring leaks during leak test or better outside the patient on the excised stomach with a bursting pressure.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Patients are randomized to two groups: group standard perfusion means that the SAP is kept between 100 and 140 mmHg by adapting depth of anesthesia, by level of post expiratory pressure or by giving vasoconstriction.
low perfusion group means that
- systolic blood pressure is kept below 100 mmHg from the first linear staple till the last by using a Clevidipine infusion to regulate the blood pressure accurate just below 100 mmHg for a short time while needed.
- goal directed fluid therapy using 100 ml/h fluid intravenous and extra load of fluid if pulse pressure variation > 20 %
- increase intra abdominal pressure (IAP) up to 20 mmHg inly during stapling and return to minimum IAP needed to achieve 3 liter workspace.
The resected stomach is removed and analyzed outside the body before throwing away:
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jan Paul Mulier, PhD
- Phone Number: 003259452490
- Email: jan.mulier@azsintjan.be
Study Contact Backup
- Name: jan Mulier
Study Locations
-
-
-
Brugge, Belgium, 8000
- Azsintjan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- primary sleeve gastrectomy
Exclusion Criteria:
- allergy to one of the drugs used intra operative
- liver, renal, cardiac or lung disease with limited function
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: low perfusion
fluid restriction based on the goal directed fluid therapy is maintained during the whole case and a state of low perfusion is created by reducing the systolic blood pressure below 100 mmHg by vasoactive medications like cleviprex or nicardipine, by increasing positive end expiratory pressure (PEEP) and by a very short period of a high IAP of 20 mmHg only during firing.
|
reduce SAP below 100 mmHg
|
Experimental: normal perfusion
Perfusion pressure is maintained above 100 mmHg with free fluid loading iv and the lowest IAP possible during the whole procedure.
|
maintain SAP above 100 mmHg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
staple thickness in mm
Time Frame: on excised stomach before being discarded within 1 hour after surgery
|
each staple is measured with thickness monitor
|
on excised stomach before being discarded within 1 hour after surgery
|
stomach thickness in mm close to staple measurement
Time Frame: on excised stomach before being discarded within 1 hour after surgery
|
with a constant pressure thickness is measured every 10 seconds till 1 minute
|
on excised stomach before being discarded within 1 hour after surgery
|
bursting pressure in mmHg
Time Frame: on excised stomach before being discarded within 1 hour after surgery
|
excised stomach is inflated with air under water with increasing pressure that is recorded.
At moment of first bubbles intra gastric pressure is recorded
|
on excised stomach before being discarded within 1 hour after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jan Paul Mulier, AZSint Jan AV
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2020
Primary Completion (Anticipated)
December 1, 2020
Study Completion (Anticipated)
December 1, 2021
Study Registration Dates
First Submitted
December 1, 2019
First Submitted That Met QC Criteria
December 6, 2019
First Posted (Actual)
December 9, 2019
Study Record Updates
Last Update Posted (Actual)
December 9, 2019
Last Update Submitted That Met QC Criteria
December 6, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2020RCTStaplingcondition
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrectomy
-
Methodist Health SystemIntuitive SurgicalRecruitingLaparoscopic Sleeve Gastrectomy | Sleeve GastrectomyUnited States
-
Samsung Medical CenterSamsung ElectronicsCompleted
-
Solvay PharmaceuticalsCompletedGastrectomyDenmark, Finland, Norway, Sweden
-
Anhui Medical UniversityUnknown
-
Miguel BurchCedars-Sinai Medical CenterTerminated
-
University of MiamiEnrolling by invitation
-
Beijing Friendship HospitalPeking Union Medical College Hospital; Beijing Tiantan Hospital; Beijing Hospital and other collaboratorsCompleted
-
Fatih Sultan Mehmet Training and Research HospitalCompletedLaparoscopic Sleeve Gastrectomy
-
The Catholic University of KoreaWithdrawnPost Gastrectomy State
-
Universiti Putra MalaysiaUnknownLaparoscopic Sleeve Gastrectomy
Clinical Trials on low perfusion state
-
Qilu Hospital of Shandong UniversityNot yet recruitingAcute Kidney Injury | Aneurysm, Dissecting
-
Riphah International UniversityCompleted
-
Czech Technical University in PragueCompletedMovement Artifacts During SpO2 Measurements | Reduced Perfusion During SpO2 MeasurementsCzechia
-
GlaxoSmithKlineCompleted
-
Daewoong Pharmaceutical Co. LTD.Hanyang UniversityUnknownErosive EsophagitisKorea, Republic of
-
The Netherlands Cancer InstituteEnrolling by invitation
-
Konkuk University Medical CenterDaewoong Pharmaceutical Co. LTD.RecruitingErosive EsophagitisKorea, Republic of
-
CAMC Health SystemTerminatedAnalgesia | SedationUnited States
-
Johann Wolfgang Goethe University HospitalCompletedPostoperative Pulmonary DysfunctionGermany